Company News
Strides Sells Pivot Path Stake to Ascent Capital
Strides Pharma sells 80% stake in subsidiary Pivot Path to Ascent Capital-led consortium for ~₹1,000m, valuing the business at ~₹2,300m post-money.
Transaction includes ₹500m primary capital infusion
